Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB
Clinical trial NCT00204529 · COMPLETED
Trial details
- NCT number
- NCT00204529
- Sponsor
- University Hospital Tuebingen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2013-05-01
- Enrollment
- 901
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.